Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / MBP134
Other

MBP134

Tracked across 1 events · 67 articles · First seen Jul 02, 2026 · Last active Jul 02, 2026

Sentiment
60
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 60
Tech
Ebola Treatment Trial Begins DRC
Impact: MBP134 is one of the monoclonal antibody treatments being evaluated in the clinical trial for its effectiveness against the Bundibugyo species of Ebola.
Apr 20, 2026 · 67 articles
ERGEN INTELLIGENCE
Track MBP134 live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.